Profile of Cervical Smears in Andaman and Nicobar Islands
Keywords:
Cervical Smear, Cancer, Women, Pap SmearAbstract
Background: About one million deaths amongst world’s women population are attributed to cancer cervix every year. Pap smear is a widely accepted screening method used to detect potentially precancerous and cancerous processes in the cervix.
Objective: To find out the prevalence of abnormal pap smear conditions in women attending Gynaecology out-patient department.
Methods: This retrospective study was carried out in the Gynaecology unit during January 1st 2018 to December 31st 2018 on 537 pap smear samples. The data was entered in excel and was presented in percentages.
Results: 43.45% had complaints of white discharge. 5.5% had epithelial cell abnormality; around 85% were negative for intraepithelial lesion or Malignancy. 4.35% of the study population had Atypical squamous cells high grade cannot be excluded ASC-H and also Adenocarcinoma. None had atypical glandular cells.
Conclusion: Regular screening camps should be organized by local government and medical fraternity to benefit women to reach the whole community.
References
Vijaya Lakshmi P, Sree Gouri SR. Study and analysis of two hundred cervical PAP smears in our hospital.
International Journal of Contemporary Medical Research 2016; 3(9): 2787-2789.
Bamanikar SA, Baravkar D, Chandanwale S et al. Study of cervical cytology and its correlation with clinical and
histopathological findings. Clin Cancer Investig J 2016; 5(5): 403-408.
Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76 10 Suppl: 1888-1901.
Bosch FX, Manos MM, Muñoz N et al. Prevalence of human papillomavirus in cervical cancer: A worldwide
perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;
(11): 796-802.
Chatterjee R, Roy A, Basu S. Detection of type specific human papillomavirus (HPV) DNA in cervical cancers
of Indian women. Indian J Pathol Microbiol 1995; 38(1): 33-42.
Mishra P, Thapa R, Dinkar AK. A study on cervical cancer screening using pap smear in urban area in state of
Meghalaya, India. Int J Reprod Contracept Obstet Gynecol 2018; 7(8): 3113-3116.
Verma A, Verma S, Vashist S et al. A study on cervical cancer screening in symptomatic women using Pap
smear in a tertiary care hospital in rural area of Himachal Pradesh, India. Middle east Fertility Society
Journal 2017; 22(1): 39-42.
Nayir T, Okyay AR, Nizlican E et al. Cervical cancer screening in an early diagnosis and screening centre
in Mersin, Turkey. Asian Pac J Cancer Prev 2015; 16: 6909-6912.
Kulkarni PR, Rani H, Vimalambike MG et al. Opportunistic screening for cervical cancer in tertiary hospitalin
Karnataka, India. Asian Pac J cancer Prev 2013; 14(9): 101-105.
Lawley TB, Lee RB, Kapela R. The significance of moderate and severe inflammation on class I Papanicolaou smear. Obstet Gynecol 1990; 76: 997-999.
Elit L, Baigal G, Tan J et al. Assessment of 2 cervical screening methods in Mongolia: Cervical cytology and
visual inspection with acetic acid. J Low Genit Tract Dis 2006; 10(2): 83-88.
Murillo R, Luna J, Gamboa O et al. Cervical cancerscreening with naked-eye visual inspection in Colombia.
Int J Gynaecol Obstet 2010; 109(3): 230-234.
Bamanikar SA, Baravkar DS, Chandanwale SS et al. Study of cervical pap smears in a tertiary hospital.
Indian Medical Gazette 2014, 250-254.
Shaki O, Chakrabarty BK, Nagaraja N. A study on cervical cancer screening in asymptomatic women
using Papanicolaou smear in a tertiary care hospital in an urban area of Mumbai, India. J Family Med Prim
Care 2018; 7(4): 652-657.
Patel MM, Pandya AN, Modi J. Cervical Pap smear study and its utility in cancer screening, to specify the
strategy for cervical cancer control. National Journal of Community Medicine 2011: 2(1): 49-51.
Downloads
Published
Issue
Section
License
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
